Health Sciences Group, Inc. Share Price

Equities

HESG

US42223A1007

Biotechnology & Medical Research

Market Closed - OTC Markets 11:13:28 24/04/2024 pm IST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Health Sciences Group, Inc. -.--% -.--%
Sales 2004 3.26 271.76 Sales 2005 0.06 5.02 Capitalization 10.25M 855M
Net income 2004 -10M -834M Net income 2005 -5M -417M EV / Sales 2004 36,98,627 x
Net Debt 2004 640K 53.42M Net Debt 2005 314K 26.18M EV / Sales 2005 17,56,45,572 x
P/E ratio 2004
-0.9 x
P/E ratio 2005
-1.57 x
Employees -
Yield 2004 *
-
Yield 2005
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.00
More quotes
Managers TitleAgeSince
President - 13/96/13
Members of the board TitleAgeSince
President - 13/96/13
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 24, 2024 at 11:13 pm IST

More quotes
Health Sciences Group, Inc. identifies, develops and commercializes products and functional food ingredients derived from natural sources to provide consumers and healthcare professionals with preventive healthcare alternatives. The Company has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The Company will launch its new product, Sequesterol Advance Cardio Formula in April 2006.
More about the company